ARCHIVES

FDA Names Director Of New Center For Tobacco Products

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

NCAB Approves Year 2000 Report; Implementation Depends On Adequate Funding Starting With FY 1986

July 12, 1985

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Pinkel, Sharp, Hausen Win GM Awards for ‘86

June 13, 1986

In Brief: House Money Bill Reportedly Will Not Increase

September 18, 1981

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002